Stock Market Today: Stocks Pull Back Amid Tax Bill Debate and Trade Talks
US stocks are mixed today as Wall Street deals with ongoing concerns over President Trump’s massive tax and spending bill and the latest developments in trade talks.
GMS Becomes The Center Of A $5 Billion Tug-Of-War — Here’s Why Everyone Wants In!
Micron Rises on Strong Earnings, But AI Growth Expectations Keep Investors Cautious
Stock Market Today: Market Rally Continues as Investor Optimism Picks Up
Business & Market Movers

Stock Market Today: S&P 500 Eyes Record High as Trade Deal Hopes and Rate Cut Bets Drive Stock Gains
·Jun 27, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023Deep Dive & Research
Healthcare & Biotech
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
Eli Lilly has expanded into cardiovascular treatment with its $1.3 billion acquisition of Verve Therapeutics, a clinical-stage gene-editing company focused on one-time therapies to lower cholesterol and prevent heart disease.
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions






Arcutis Biotherapeutics Surges Amid Takeover Speculation: Why Large Pharma Should Pay Attention!


Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story

Tech & Energy
Google’s Rough 2025 Could Be Setting the Stage for a Comeback
2025 has been a challenging year so far for Alphabet (GOOG, GOOGL), with the stock down about 9% year-to-date.



Is This The Beginning of the End for Google Search? Alphabet’s Future Hangs in the Balance!

Meta’s $14.8 Billion AI Blitz: Inside Zuckerberg’s High-Stakes Superintelligence Gamble!

Arista Networks’ Stunning Reversal: From Avoided To Adored — Why Wall Street Sees Strong Upside Ahead!

